Stéphane Pyronnet

5PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical roboticsMedical devicesPredictive and prognostic markersHuman impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 26, 2026
CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas.

|May 13, 2026
Tissue- and tumor-type-specific expression of internal-promoter-driven YEATS-domain-devoid isoforms of MLLT1 and MLLT3.

|Jan 03, 2025
A strong internal promoter drives massive expression of YEATS-domain devoid MLLT3 transcripts in HSC and most lethal AML.

Chloé Bessière, Ahmed Zamani, Romain Pfeifer

|Nov 13, 2021
Gene Expression Signature Associated with Clinical Outcome in ALK-Positive Anaplastic Large Cell Lymphoma.

Camille Daugrois, Chloé Bessiere, Sébastien Dejean

|Feb 12, 2021
ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?

Kelly Féral, Manon Jaud, Céline Philippe

Pageof 1

Frequent Collaborators

2 joint publications

Fabienne Meggetto

2 joint publications

Chloé Bessière

2 joint publications

Marina Bousquet

1 joint publications

Kevin Rouault-Pierre